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Metabolic engineering increasingly depends upon RNA technology to customly rewire the
metabolism to maximize production. To this end, pure riboregulators allow dynamic gene
repression without the need of a potentially burdensome coexpressed protein like typical
Hfq binding small RNAs and clustered regularly interspaced short palindromic repeats tech-
nology. Despite this clear advantage, no clear general design principles are available to de
novo develop repressing riboregulators, limiting the availability and the reliable development
of these type of riboregulators. Here, to overcome this lack of knowledge on the functionality
of repressing riboregulators, translation inhibiting RNAs are developed from scratch. These
de novo developed riboregulators explore features related to thermodynamical and struc-
tural factors previously attributed to translation initiation modulation. In total, 12 structural
and thermodynamic features were defined of which six features were retained after remov-
ing correlations from an in silico generated riboregulator library. From this translation
inhibiting RNA library, 18 riboregulators were selected using a experimental design and
subsequently constructed and co-expressed with two target untranslated regions to link the
translation inhibiting RNA features to functionality. The pure riboregulators in the design of
experiments showed repression down to 6% of the original protein expression levels, which
could only be partially explained by a ordinary least squares regression model. To allow reli-
able forward engineering, a partial least squares regression model was constructed and val-
idated to link the properties of translation inhibiting RNA riboregulators to gene repression.
In this model both structural and thermodynamic features were important for efficient gene
repression by pure riboregulators. This approach enables a more reliable de novo forward
engineering of effective pure riboregulators, which further expands the RNA toolbox for
gene expression modulation.
Author summary
To allow reliable forward engineering of microbial cell factories, various metabolic engi-
neering efforts rely on RNA-based technology. As such, programmable riboregulators
allow dynamic control over gene expression. However, no clear design principles exist for
de novo developed repressing riboregulators, which limits their applicability. Here, various
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engineering principles are identified and computationally explored. Subsequently, various
design criteria are used in an experimental design, which were explored in an in vivo
study. This resulted in a regression model that enables a more reliable computational
design of repression small RNAs.
Introduction
Over the last decade, synthetic biology and systems biology spurred major advances in meta-
bolic engineering, resulting in several economically competitive production processes for both
bulk and fine chemicals from renewable resources, revolutionizing industrial biotechnology
[1, 2, 3, 4, 5]. In this context, interfering with the native metabolism of the production host is a
necessity to redirect the metabolic flux towards the product of interest with a view to maximiz-
ing productivity [6, 7]. Traditionally, tuning the cellular metabolism has been done through
gene deletions, which is impossible for numerous essential genes often related to various bio-
synthetic pathways [8, 9]. As such, maximizing various production pathways requires tools
able to specifically reduce gene expression. To this end, zinc fingers and transcription activa-
tor-like effectors were engineered to dynamically control transcription of a specific gene
through DNA-binding proteins [10, 11]. These custom gene expression regulators are outper-
formed by recently emerged clustered regularly interspaced short palindromic repeats interfer-
ence (CRISPRi), an adaptation of the type II clustered regularly interspaced short palindromic
repeats (CRISPR) system controlling transcription through reversible binding of a RNA-
guided deactivated Cas9 nuclease to DNA [12]. Various metabolic engineering efforts in mul-
tiple organisms used this CRISPRi technology to successfully repress a series of specific genes
in a dynamic way, hereby ameliorating the desired product formation [13, 14, 15].
Alternative approaches to control gene expression on the translational level employ small
RNAs (sRNAs) to repress protein production by blocking translational initiation, enabling
metabolic flux redirection at will [9, 16, 17, 18]. Similar to the CRISPRi technology, which
requires a small guide RNA (sgRNA) able to bind to the dCas9 protein, these types of sRNAs
also require a protein binding RNA motif as they rely on the stabilizing Hfq protein. This Hfq
based riboregulation has been used in various metabolic engineering efforts for gene repres-
sion and uses known Hfq binding motifs to combine with an antisense part, targeting specific
mRNA. The dependence on coexpressed proteins might cause increased metabolic burden,
which can lead to long term genetic instability and unexpected behaviour [14, 19, 20]. To
reduce these undesired effects, gene expression modulation systems are preferred that solely
rely on RNA [21]. These pure riboregulators require less cellular resources by avoiding the
extra translation step, hereby lowering metabolic burden [21]. For example, riboregulator
technology is successfully used to precisely downregulate specific genes, hereby redirecting
metabolite fluxes towards the phenotype of interest [22, 23, 24]. Also, pure riboregulators,
which do not require proteins, harness large potential for the construction of fast responding
RNA circuitery [17, 25, 26, 27]. However, practical applications of pure riboregulators are the
result of thorough laborious, inefficient and impractical screening of multiple designs com-
prising hundreds of nucleotides [22, 23].
Early pure riboregulators were designed to hybridize the translation initiation region.
The RNA architecture in this region plays a pivotal role in the translation initiation process,
enabling gene expression through RNA-RNA interactions [28]. This apparent link between
RNA structure and biological function, in combination with the ease and reliability of
RNA secondary structure prediction, drove several gene silencing efforts solely using RNA.
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However, successful attempts to modulate gene expression using solely trans expressed RNA
employed a variety of features [29, 30, 31]. As such, interfering with translation initiation
using solely RNA-RNA interactions has been attributed to various features of the trans
expressed RNA molecule [26, 29, 30, 32, 33, 34, 35].
These features are classified as either structural or thermodynamic features. Several struc-
tural features of riboregulators modulating translation initiation through RNA-RNA interac-
tions include post-transcriptional ribosome binding site (RBS) occlusion [33, 34], formation of
paired termini structures [32], and manipulation of the structural accessibility of the target site
[29, 35]. Besides structural constraints, various thermodynamic features were previously used
to design and optimize translation interfering riboregulators, mainly comprising formation
and activation energies [26, 33]. Formation energies are typically obtained by estimating the
minimum free energy (MFE) [33]. Despite the importance of activation energy, various esti-
mation methods for the activation energy were previously used to create functional riboregula-
tors [26, 33]. These methods rely on the initial monomeric structures and are based on the
assumption that the unbound nucleotides in this state initiates the RNA-RNA complex forma-
tion [26, 33].
This broad range of employed features indicates the lack of consensus in literature, which
limits the general applicability of the current design rules for pure riboregulators (without
using coexpressed proteins). For instance, simply expressing the antisense strand does not
fully repress gene expression on the post-transcriptional level [22, 23]. As such, various types
of riboregulators suitable for metabolic engineering purposes were created using a number
of different riboregulator design features, once again indicating the lack of consensus in litera-
ture on the development of riboregulators [26, 33, 36]. Overall, these riboregulators are either
developed from a natural existing RNA regulator chassis or created de novo, the latter being
the most interesting as this enables forward engineering in a broader context [33, 36]. More-
over, only activating riboregulators were created de novo, which limits the construction of
genetic circuitery using solely RNA.
Here, we propose a framework for the de novo design of pure riboregulators, referred to as
translation inhibiting RNAs (tiRNAs), which repress gene expression by blocking translation
initiation. To develop this predictive framework, the influence of all features previously attrib-
uted to post-transcriptional gene modulation were analyzed in a design of experiments (DOE).
This experimental design allows exploration of the feature landscape and evaluation of their
influence on gene repression. First, using a library of tiRNA, all features were analyzed in silico
to create a collection of features with maximal information content. Next, the performance
of de novo designed tiRNAs was evaluated in vivo, and used to construct an ordinary least
squares (OLS) and a partial least squares (PLS) model which links riboregulator features to
gene repression.
Methods
Strains and growth conditions
Escherichia coli strain DH10B (Invitrogen) was used for both plasmid construction and fluo-
rescence measurement purposes. Unless otherwise stated, all products were purchased from
Sigma-Aldrich (Diegem, Belgium). For plasmid construction and fluorescence measurements
strains were grown in grown in lysogeny broth (LB) and MOPS EZ rich medium (Teknova,
Bioquote, York, United Kingdom) at pH 7.4, respectively at 37˚C with shaking. LB was com-
posed of 1% tryptone-peptone (Difco, Erembodegem, Belgium), 0.5% yeast extract (Difco)
and 1% sodium chloride (VWR, Leuven, Belgium). LB agar (LBA) plates contain the same
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components as LB with the addition of 1% agar. If required, medium was supplemented with
100 μg ml-1 ampicillin and 50 μg ml-1 kanamycin.
Plasmids
pSilence plasmids were medium-copy vectors (pBR322 origin of replication (ori) and ampicil-
lin resistance marker, originating from pSB6A1 [37]) with a truncated version (all nucleotides
after the transcription start were removed) of the proD [38] as promoter and BBa_B1006 [39]
as terminator for tiRNA expression (see Figure A in S1 Text for more details), and pTarget
plasmids were low-copy vectors (pSC101 ori and kanamycin resistance marker, originating
from pCL1920 [40]) with proB [38] as promoter, mKate2 [41] as reporter gene, rnpB T1 [39]
as terminator, and the target 5’ untranslated region (UTR) (see Figure B in S1 Text for more
details). The reporter mKate2 was used due to its low background and good fluorescent pro-
tein properties (brightness and maturation time) [41]. A schematic overview of the two plas-
mid types used in this study (pSilence and pTarget) is shown in Figure C in S1 Text.
The control plasmids used in this study were pBlank1 and pBlank2, which are the same vec-
tors as the pSilence and pTarget plasmids, respectively. The pBlank1 plasmid comprises only
the vector backbone and pBlank2 contains the mKate2 open reading frame (ORF) and rnpB
T1 [39] as terminator, thus without promoter and UTRs. All plasmids used in this study were
constructed using Golden Gate [42] and CPEC [43] assembly. DNA oligonucleotides were
commercially ordered from IDT (Leuven, Belgium) and DNA sequences of every constructed
plasmid were verified using sequencing services (Macrogen Inc., Amsterdam, The Nether-
lands). All tiRNA sequences used in this study are listed in Table A in S1 Text. Details of
the plasmids and DNA sequences used in this study are listed in Table B and C in S1 Text,
respectively.
In vivo fluorescence and optical density (OD) measurements
For in vivo assessment of translational inhibition, strains were plated on LBA plates containing
100 μg ml-1 ampicillin and 50 μg ml-1 kanamycin. After overnight incubation, three colonies
were inoculated in 150 μl MOPS EZ rich medium, covered by a Breathe-Easy sealing mem-
brane (Sigma-Aldrich), and grown overnight on a Compact Digital Microplate Shaker
(Thermo Scientific) at 800 rpm and 37˚C. Subsequently, these cultures were 1:100 diluted in
150 μl of fresh MOPS EZ rich medium and grown on a Compact Digital Microplate Shaker
until late log phase (6 h) at 800 rpm and 37˚C. Subsequently, fluorescence and OD were mea-
sured using a Tecan M200 pro microplate reader. Precultures were grown in Greiner bio-one
(Vilvoorde, Belgium) polystyrene F-bottom 96 well plates. Fluorescence and OD measure-
ments were performed after growth in Greiner bio-one (Vilvoorde, Belgium) black μclear 96
well plates. For measuring mKate2 expression an excitation wavelength and an emission wave-
length of 588 nm and 633 nm were used, respectively. OD was measured at a wavelength of
700 nm to reduce bias in estimates of cell abundance [44].
Fluorescence data analysis
For fluorescence measurements, two types of controls were used on every 96-well microtiter
plate, i.e., a MOPS EZ rich medium blank and E. coli DH10B cells without fluorescent protein
expression (contains pBlank1 and pBlank2 plasmids). The medium blank was used to correct
the background OD (ODbg) of the medium. The fluorescence of the strain without fluorescent
protein expression (FPbg) was used to correct for the background fluorescence of E. coli. For all
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The relative protein expression was defined as follows:
Relative protein expression ð%Þ ¼
ð FPODÞcorrected with riboregulator
ð FPODÞcorrected without riboregulator
 100 ð2Þ
Feature quantification using RNA bioinformatics
For each tiRNA candidate 12 features were calculated (see Table 1 for detailed definitions),
which were determined based on various previous riboregulator efforts described in literature
[26, 29, 33, 34, 35]. The tiRNA features are classified in two main groups: thermodynamic
properties and structural constraints. All intra- and intermolecular interactions between RNA
molecules were predicted using RNAfold [45] and RNAcofold [46], respectively. Both RNA
secondary structure prediction algorithms were available through the Vienna RNA package
[47] and were used with only the options –noLP -d2 and an accuracy of 10-100, all other set-
tings are set to the default setting. Suboptimal structures of RNA molecules are drawn with
probabilities equal to their Boltzmann weights using RNAsubopt [48]. The intermolecular
binding between the unbound part of the tiRNA and the UTR is estimated by the RNAup
Table 1. Detailed definitions of all features (free energy of the tiRNA monomer (EA), free energy of the tiRNA-
tiRNA dimer (EAA), free energy of the tiRNA-UTR dimer (EAB), formation energy of the tiRNA-tiRNA dimer
(FAA), formation energy of the tiRNA-UTR dimer (FAB), total seed energy (ETS), intermolecular binding seed
energy (EIS), probability availability of UTR (PAU), RBS coverage of length 5 (RBS5), RBS coverage of length 11
(RBS11), paired termini (PT), and the length of the translation inhibiting RNA (tiRNA) (L)) used in the initial in
silico screening of the tiRNA library for repression of a target untranslated region (UTR). This UTR contains a
ribosome binding site (RBS) and controls the coding DNA sequence (CDS) of the reporter protein. All binding proba-
bilities of monomers and dimers are respectively derived from base pairing probability matrices estimated by RNAfold
[45] and RNAcofold [46].
Name Definition of the tiRNA feature
EA ΔGtiRNA; free energy of the tiRNA monomer, calculated using RNAfold [45].
EAA ΔGtiRNA-tiRNA; free energy of the tiRNA-tiRNA dimer, calculated using RNAcofold [46].
EAB ΔGtiRNA-UTR; free energy of the tiRNA-UTR dimer, calculated using RNAcofold [46].
FAA Formation energy of the tiRNA-tiRNA dimer; ΔGtiRNA-tiRNA—2 ΔGtiRNA.
FAB Formation energy of the tiRNA-UTR dimer; ΔGtiRNA-UTR—ΔGtiRNA—ΔGUTR. With ΔGUTR defined as free
energy of the UTR (including first 50 nucleotides of the CDS RNA), calculated using RNAfold [45].
ETS Average minimal total energy (gains from intermolecular binding and needs to ‘open’ the binding site) for
the binding of unbound parts of the tiRNA monomer to the target UTR, calculated using RNAup [49] for
100 suboptimal structures randomly drawn from Boltzmann ensemble [48]
EIS Average minimal energy gained from intermolecular binding of unbound parts of the tiRNA monomer to
the target UTR, calculated using RNAup [49] for 100 suboptimal structures randomly drawn from
Boltzmann ensemble [48]
PAU Weighted average of the relative number of unbound nucleotides in the UTR monomer with the relative
number of nucleotides bound by the tiRNA molecule in the tiRNA-UTR dimer complex as weights.
RBS5 The RBS coverage (relative number of bound nucleotides) in the region CRBS−2 to CRBS+2, where CRBS is
defined as the weighted average of the nucleotides in the UTR bound by the 16S rRNA.
RBS11 The RBS coverage (relative number of bound nucleotides) in the region CRBS−5 to CRBS+5, where CRBS is
defined as the weighted average of the nucleotides in the UTR bound by the 16S rRNA.
PT Average number of bound nucleotides between the first and the second half of the a tiRNA sequence
calculated for 100 suboptimal structures randomly drawn from Boltzmann ensemble [48].
L The length of the tiRNA (nt)
https://doi.org/10.1371/journal.pcbi.1006170.t001
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algorithm [49]. All calculations were done using Python scripting on an Intel Xeon E5-2670
(2.60GHz) Linux (Debian) server. Details on the quantification of thermodynamic and struc-
tural properties of tiRNA molecules are available in Supplementary Methods 1.1.
Statistical calculations and experimental design
All statistical calculations and analyses were performed in R. Unless otherwise stated, error
bars represent the standard deviation (n = 3). All coefficient of determinations (R2s) were cal-
culated using the hydroGOF package in R.
Experimental design. The 26-2 fractional factorial design, which comprises solely UTR1,
was generated using the R package FrF2 [50]. In the DOE, the -1 and 1 state of the factors were
defined as the 0.1 and 0.9 p-quantiles of the original feature distribution, respectively. The cen-
ter points are designed to be [0, 0, 0, 0, 0, 0], where 0 represents the average of the absolute val-
ues of the tiRNA features in the initial library of 1,500,000 possible tiRNA candidates. For each
feature in the experimental design all data points (Xi) were centered and scaled based on the
0.1 and 0.9 p-quantiles (qX,0.1 and qX,0.9) of the original distribution of feature X (Eq 3).
~Xi ¼
Xi   ðqX;0:9 þ qX;0:1Þ=2
ðqX;0:9   qX;0:1Þ=2
ð3Þ
The centered features ~X were only used in the analysis of the DOE. All data points of the
26-2 fractional factorial design are shown in Table D in S1 Text. The features FAB and EIS were
multiplied by -1 to obtain positive regression coefficients as these were expected to be nega-
tively correlated with tiRNA performance.
Regression models
Ordinary least squares (OLS) regression. The OLS regression was done in R. The OLS
regression model was calibrated using the absolute (unprocessed) values of FAB for all data
points, including data from target UTR2. Eq 4 depicts the linear relationship obtained from the
OLS regression, where Yj is the relative protein expression when tiRNA j is present, Xj,1 is fea-
ture FAB of tiRNA j, β0 and β1 are regression coefficients and j is an error term.
log
10
ðYjÞ ¼ b0 þ b1Xj;1 þ j ð4Þ
Partial least squares (PLS) regression. The PLS regression was done in R with the pack-
age pls [51]. The PLS model was validated by splitting the data set from UTR1 and UTR2 in a
training set and validation set (5:1 ratio). Subsequently, the training set was used to create the
model by leave-one-out cross validation where predictors were scaled prior to regression (by
dividing each variable the sample standard deviation). In PLS regression the matrix of predic-
tors X is decomposed into orthogonal score matrix T (projection of X) and loadings matrix P,
circumventing potential collinearities in the data set:
X ¼ T P ð5Þ
Subsequently, Y is regressed on the scores T (and not X). The specific PLS algorithm used is
kernel PLS, which was described by Dayal et al [52].
Results and discussion
The trans expressed tiRNAs are de novo designed to inhibit translation initiation of a gene of
interest, the rate-limiting step in translation [53], as depicted in Fig 1A. Contrary to previous
De novo developed post-transcriptional riboregulators
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Fig 1. A) Schematic overview of the translation inhibiting RNA (tiRNA) working mechanism B) Workflow for the in silico
selection of the tiRNAs comprising the design of experiments (DOE) to unravel design principles. The defined tiRNA
features (free energy of the tiRNA monomer (EA), free energy of the tiRNA-tiRNA dimer (EAA), free energy of the
tiRNA-UTR dimer (EAB), formation energy of the tiRNA-tiRNA dimer (FAA), formation energy of the tiRNA-UTR dimer
(FAB), total seed energy (ETS), intermolecular binding seed energy (EIS), probability availability of UTR (PAU), RBS
coverage of length 5 (RBS5), RBS coverage of length 11 (RBS11), paired termini (PT), and the tiRNA length (L)) are
calculated for a tiRNA library created based on a specific target 5’ untranslated region (UTR). C) In vivo assessment of the
tiRNA in the designed experiment D) Linking features to tiRNA performance through modeling. The fluorescence (FP) per
optical density (OD) for a strain was calculated as follows: (FP/OD)corrected = (FP-FPbg)/(OD-ODbg) with FPbg = fluorescence
of the strain without fluorescent protein expression and ODbg = OD of the medium. The relative protein expression (%) was
De novo developed post-transcriptional riboregulators
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efforts to construct repressing riboregulators, these RNA devices are constructed from scratch
without a functional chassis, which is often based on a natural occurring RNA regulation
device [26, 54, 55]. To enable reliable forward engineering of tiRNAs, a workflow to improve
the de novo development of repressing riboregulators through DOE guided exploration of the
sequence space was developed and optimized (see Fig 1B–1D). First, possibly important fea-
tures for translational inhibiting riboregulators are derived from literature. Secondly, the num-
ber of features are reduced by removing correlations. Subsequently, this reduced set of tiRNA
properties is used in an experiment designed to unravel design principles to build effective
tiRNA molecules. In the DOE, tiRNAs are constructed that explore the feature space in an
intelligent way. Ultimately, thoroughly analyzing the performance of the constructed tiRNAs
with varying features can improve the knowledge on the structure-function relationship,
which correlates to better predictability of de novo created riboregulators [26, 33, 36].
Identification of determinative features of repressing riboregulators
In total, 12 potentially determinative features of efficient tiRNA were identified and derived
from literature (see Fig 2 and Table 1 for more details). These 12 features represent all design
principles previously used in riboregulator construction. Five out of the 12 indentified features
are based on structural properties. Namely, two features are defined to quantify RBS coverage,
i.e. RBS5 and RBS11, which is the average base pairing probability in the region of the RBS
with length 5 and 11, respectively. The third feature quantifies the amount of paired termini
(PT) and the availability of the UTR is evaluated by the PAU property. The last structural fea-
ture is determined by the length of the tiRNA (L). The remaining seven defined features are
based on properties relating to thermodynamics. The energy required for the formation of the
tiRNA-tiRNA dimer and the tiRNA-UTR dimer are defined as FAA and FAB, respectively.
These formation energies are calculated based on the estimated Gibbs free energy of the final
defined as the (FP/OD)corrected in presence of the riboregulator divided by the (FP/OD)corrected in the absence of the
riboregulator.
https://doi.org/10.1371/journal.pcbi.1006170.g001
Fig 2. Schematic overview of all potentially determinative features of translation inhibiting RNAs (tiRNAs): 1) free energy of the tiRNA
monomer (EA), 2) free energy of the tiRNA-UTR dimer (EAB), 3) free energy of the tiRNA-tiRNA dimer (EAA), 4) formation energy of the
tiRNA-UTR dimer (FAB), 5) formation energy of the tiRNA-tiRNA dimer (FAA), 6) intermolecular binding seed energy (EIS), 7) total seed
energy (ETS), 8) RBS coverage of length 5 (RBS5), 9) RBS coverage of length 11 (RBS11), 10) probability availability of UTR (PAU), 11) paired
termini (PT), and 12) tiRNA length (L).
https://doi.org/10.1371/journal.pcbi.1006170.g002
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dimer and both initial monomer states, which are described by the EA, the EAA, and the EAB
features. In addition, two features describe the activation energy: intermolecular binding seed
energy (EIS) and the total seed energy (ETS). Notably, most previous approaches to specify
design rules for riboregulators only take the MFE structures into account, simplifying the
Boltzmann ensemble of RNA secondary structures and the corresponding complex dynamic
energy landscape of regulatory RNAs [56]. The workflow followed here to improve the de novo
development of repressing riboregulator through DOE guided exploration of the sequence
space is depicted in Fig 1B. Here, simplifications were minimized by taking the Boltzmann
ensemble into account as much as possible.
Feature space reduction using correlation analysis
A library of 1,500,000 unique possible tiRNA sequences with length 20, 30 or 40 nucleotides
(nt) was created in silico based on UTR1 (see Table E in S1 Text) using custom perl code. To
generate this library, sequences were generated by combining a random number of different
(randomly chosen) parts (length>= 2 nt) of the reverse complement of UTR1 and keeping the
order of occurrence of these different parts, as effective riboregulators typically contain parts
of the reverse complement of the target UTR.
The amount of correlations between the various features was reduced by analyzing existing
correlations between all features, and subsequently removing correlations above a set thresh-
old of 0.75. This was done by calculating the Pearson correlation coefficients (PCCs) (see Fig
3). The correlations between FAA, EA, and EAA, between FAB and EAB, and between EIS
and ETS are caused by one or more features being used in the calculation of another feature.
Also, RBS5 and RBS11 are correlated, which can be explained by the fact that the RBS region
covered by RBS5 is also covered by RBS11. Finally, the length of tiRNA (L) is correlated with
EAB as the stability of the tiRNA-UTR complex increases (lower Gibbs free energy) with the
tiRNA length. The feature space was reduced, while minimizing information loss, by removing
correlations between various features. To this end, one feature of a set of correlated features
was selected (|PCC|> 0.75). The reduced set of the tiRNA features Xi with limited correlations,
i.e. FAA, FAB, EIS, PAU, RBS11, and PT, was used in a DOE to unravel the features with the
most influence on the repression efficiency of these pure riboregulators (see Fig 1B). More
specifically, a fractional factorial 2-level design was used with a resolution of IV (26-2 design),
comprising two center points and 16 factorial points. After rescaling all features (see Section
and Table D in S1 Text for details), the 18 best suiting data points were selected from the
library of 1,500,000 tiRNA candidates. The density of all tiRNA features of the complete con-
structed library with the 0.1 and 0.9 p-quantiles is depicted in Figure D in S1 Text. Because the
features are calculated based on the sequence of a generated tiRNA candidate, the factors can-
not be set to a specific value. Instead, suitable sequences were selected from the tiRNA candi-
date library based on the residual sum of squares (RSS) between the real data point of the
experimental design and the actual features a this specific candidate (overall, average RSS is
0.59). The selected tiRNA sequences (one feature was selected from features with a PCC above
0.75) with their corresponding theoretical data point are depicted in Table A in S1 Text and
Fig 4A, respectively.
In vivo analysis of tiRNA performance
Subsequently, the performance of these 18 tiRNAs in the DOE was evaluated in vivo as
depicted in Fig 4A. In this experimental setup, the tiRNA molecules are expressed from pSi-
lence plasmids carrying the pBR322 ori, which have an approximately fourfold higher copy
number compared to the pSC101 ori of the pTarget plasmids utilized for UTR expression [37],
De novo developed post-transcriptional riboregulators
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and are under the control of the proD promoter, which showed 8.4 fold higher transcriptional
activity compared to the proB promoter used for UTR expression [38]. The overall higher rela-
tive tiRNA expression (compared to its target UTR) was chosen based on the fact that trans
acting sRNA typically require relatively higher expression of the sRNA compared to its target,
in both natural and synthetic sRNA regulation systems [57, 58].
To enlarge the data set, the pSilence plasmids were co-transformed with the pTarget plas-
mid containing UTR1 or UTR2 (a truncated version of UTR1, see Table E in S1 Text), respec-
tively, evaluating the repression efficiency of the tiRNAs in the DOE. Compared to UTR1,
UTR2 results in 3.3 times less production of fluorescent protein in absence of any riboregulator
(see Figure E in S1 Text) although the thermodynamic stability of UTR1 is much higher than
UTR2 (-27.6 and -17.3 kcal/mol, respectively), which is in contrast to previous studies inversely
relating translation to the Gibbs free energy of the UTR [59, 60]. Moreover, the UTR2 forms
much less base pairs in the region around the Shine-Dalgarno (SD) sequence (see Figure E in
S1 Text), making the RBS possibly more accessible. However, the removal of a terminal stem
loop in the 5’ UTR could decrease mRNA stability by exposing the RNA to RNases, resulting
in a decrease in fluorescence [61, 62].
Fig 3. Heatmap of the Pearson correlation coefficients (PCCs) between all features of the translation inhibiting RNA (tiRNA) library, with
L = length, EA = free energy of the tiRNA monomer, EAA = free energy of the tiRNA-tiRNA dimer, EAB = free energy of the tiRNA-UTR
dimer, FAA = formation energy of the tiRNA-tiRNA dimer, FAB = formation energy of the tiRNA-UTR dimer, ETS = total seed energy,
EIS = intermolecular binding seed energy, PAU = probability availability of UTR, RBS5 = RBS coverage of length 5, RBS11 = RBS
coverage of length 11, and PT = paired termini (see Table 1 and Fig 2). The fluorescence (FP) per optical density (OD) for a strain was
calculated as follows: (FP/OD)corrected = (FP-FPbg)/(OD-ODbg) with FPbg = fluorescence of the strain without fluorescent protein expression and
ODbg = OD of the medium. The relative protein expression (%) was defined as the (FP/OD)corrected in presence of the riboregulator divided
by the (FP/OD)corrected in the absence of the riboregulator.
https://doi.org/10.1371/journal.pcbi.1006170.g003
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The outcome of the designed experiment is depicted in Fig 4C. In this DOE tiRNA1
([-1,-1,-1,-1,-1,-1]) does not possess any of the features and serves as a control when com-
bined with UTR1 to determine the burden of the promoter used, which is not significantly
different from the strain containing pBlank1 and pTarget1. This is in accordance with
Fig 4. The results from the designed experiment to unravel the principles for translation inhibiting RNA (tiRNA) design. (A) The practical
execution of the design of experiments (DOE). All tiRNAs, representing a data point in the DOE, are coexpressed with the target untranslated
region (UTR) and the riboregulator efficiency is determined. (B) All tiRNAs with corresponding feature data point in the DOE, where the
features are calculated using UTR1. (C) The tiRNA performance, expressed in relative protein expression, where lower expression represents
more effective tiRNAs. The performance was evaluated using both UTR1 and UTR2. The 100% relative protein expression represents the protein
expression in absence of the tiRNA. Error bars represent standard deviation (n = 3).
https://doi.org/10.1371/journal.pcbi.1006170.g004
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literature determining the burden of RNA riboregulators, which is low compared to other
types of gene expression regulation [21]. The activity of the de novo designed riboregulators
shows that almost all tiRNAs were active. Specifically, eight of the 18 tiRNAs targetting
UTR1 inhibit the translation initiation of UTR1 with more than 75%. The most repressing
tiRNAs reduce protein expression of UTR1 to about 6% of the original expression level. The
highest dynamic range of translation repression among all data points is 16, which is higher
than previously described repressing riboregulators [26]. Moreover, these tiRNA are created
de novo, without using a naturally occurring functional chassis.
Overall, the repression levels on UTR2 are comparable to those of UTR1, indicating that the
truncated part distal to the RBS BBa_B0032 is less important for riboregulator activity. There
is a clear difference in repression efficiency between tiRNA1 ([-1,-1,-1,-1,-1,-1]) and tiRNA16
([1, 1, 1, 1, 1, 1]), showing the importance of at least one of the selected features for transla-
tional inhibition. Another interesting fact is the high repression rate of tiRNA17 and tiRNA18,
which are the center points of the DOE. The good performance of these center points indicate
that choosing less extreme values can also result in effective translational repression.
Linking features to tiRNA activity
To unravel underlying design principles of repressing tiRNAs, an OLS linear regression analy-
sis was performed in a first approach. To this end, a linear regression model was applied using
all data points in the experimental design. All relative expression percentages from all data
points of the experimental design are plotted against all normalized features (with only UTR1
as target) in Figure F in S1 Text. The predicted MFE secondary structure of the 18 different
tiRNA:UTR complexes for UTR1 and UTR2 is depicted in Figure G and H in S1 Text, respec-
tively. Relative expression percentages plotted against all absolute features for all data (includ-
ing the repression percentages of UTR2) are depicted in Figure I in S1 Text. Only two factors
in the linear model had a significant influence, namely FAB (p< 0.05) and PT (p< 0.1). Fac-
tors FAB and PT also had significant influence on several other reported riboregulator systems
with or without the aid of Hfq [9, 18, 26, 32, 33, 36]. When using only these two features in a
linear regression model, only the factor FAB was significant (p< 0.05), while factor PT turned
out to be not significant (p> 0.1). As the factor FAB is based on thermodynamic properties,
it was hypothesized that the relation between FAB and the relative protein expression is expo-
nential. Therefore, a linear model was used to relate the logarithmic of relative protein expres-
sion percentage to the tiRNA feature FAB (see Eq 4). The outcome of this OLS regression is
depicted in Fig 5. Despite the significant influence of FAB in the DOE, this basic model is still
unable to explain all tiRNA functionality which is reflected by the fact that the majority of the
data points are not within the 95% confidence interval of the OLS model.
Data driven approaches using regression methods have previously been successful in bio-
logical engineering [63, 64] and, more specifically, forward design of various RNA devices [26,
36, 65]. Therefore, in a second approach, PLS regression was performed. To maximize the
information possibly linked to tiRNA activity, the 12 defined features were included.
To perform the PLS regression, all data points from UTR1 and UTR2 were split into two
subsets: one set used for model calibration, i.e. training set, and one independent set used for
model validation, i.e. test set. The latter set was selected by randomly picking tiRNAs from
three groups which are ordered based on the averaged gene expression of both UTR1 and
UTR2. The test data comprised tiRNA9, tiRNA12, and tiRNA18, all other tiRNAs were used in
the training set. Before regression, the absolute values of the tirna features were scaled through
division by the sample standard deviation. Model calibration was done using all 30 data points
from the training set and uses 12 features (k = 12) describing tiRNA performance. The final
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model contained 4 latent variables and was selected based on the root mean squared error of
prediction and the explained Y variance. By using the training set, a final PLS model contains
63.9% of the X variance, which explained 50.4% variance of the response variable and a R2
(describing the model efficiency) of 0.50 (see Fig 6). To validate this PLS model, the indepen-
dent validation set was used to assess the quality of the PLS model. The R2 of this validation set
was 0.69, indicating that the model successfully explains tiRNA activity. To identify the most
important factors in the PLS regression model, all estimated regression coefficients are calcu-
lated (see Table F in S1 Text for all coefficients and scaling factors). The regression coefficients
of the 12 tiRNA features are shown in Figure J in S1 Text. The cumulative loadings of the 4
components and the biplot of the first two components are depicted in Figure K and L in S1
Text, respectively. From these estimates the formation energy of the UTR-tiRNA complex is
again inversely correlated to the final protein expression as both regression coefficients of EAB
Fig 5. Plot of the ordinary least squares (OLS) regression of the linear model, linking log10 of the relative protein expression to
the translation inhibiting RNA (tiRNA) feature formation energy of the tiRNA-UTR dimer (FAB). All data points were used,
including the effect of the tiRNAs on both untranslated region 1 (UTR1) and UTR2. The gray area depicts the 95% confidence
interval of the OLS linear regression. Error bars represent the standard deviation (n = 3).
https://doi.org/10.1371/journal.pcbi.1006170.g005
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and FAB are positive. This link between dimer stability and riboregulator performance was
also previously observed in other RNA devices [26, 33]. Other observations are the negative
relation between FAA and protein expression, indicating that a stable tiRNA-tiRNA dimer
complex decreases tiRNA efficiency. Besides these thermodynamic factors, structural features
PAU and PT are inversely correlated to protein expression. Thus, as described in literature
[29, 32, 35], target nucleotide availability and the number of paired termini (linked to RNA sta-
bility) in the riboregulator monomer is important for repression efficiency. Contrary to previ-
ous studies, activation energy and total RBS occlusion has a rather limited influence on gene
repression.
Overall, the PLS modelling approach employed here successfully predicts tiRNA activity
based on the described 12 features, which were defined based on literature. However, various
Fig 6. Validation of partial least squares (PLS) regression model predicting relative protein expression from 12 predictors
(features of translation inhibiting RNA (tiRNA)). Plot of experimental versus predicted relative protein expression via PLS model
for the training set (used for model calibration) and the validation set (used to test the model efficiency; coefficient of determination
(R2) equal to 0.69). Error bars represent the standard deviation (n = 3).
https://doi.org/10.1371/journal.pcbi.1006170.g006
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features used in previously described efforts were quantified using different methods [26, 33].
This lack of standardized methods to determine thermodynamic and structural features of
riboregulators complicates forward engineering of riboregulators. Also, the diverse range of
features required to explain tiRNA functionality is an indication of the complex nature of the
regulatory mechanism of riboregulation. As such, RNA regulation might require properties
unknown today, which can be discovered using recently developed technologies allowing
detailed structural analysis of riboregulators with a high-throughput. For instance, SHAPE-Seq
allows in vivo characterization of RNA structure by coupling chemical probing techniques to
next-generation sequencing technology [66, 67].
Conclusions
The developed approach allows de novo design of translation inhibiting riboregulators, which
further broadens the RNA regulator toolbox. From the 18 constructed tiRNAs molecules
designed in the DOE eight tiRNAs repressed protein production with more than 75%. The
riboregulators described in this paper do not require any coexpressed proteins, which
increases their applicability to build complex genetic circuitry. For instance, it allows to recon-
stitute a RNase III site (resulting in RNA degradation [68]) or interference with guide RNAs of
a CRISPR system to obtain complex biological functions. To further improve riboregulator
design several basic modelling approaches were employed. However, these basic efforts were
unable to fully explain tiRNA performance, indicating the complexity of riboregulator repres-
sion. Previous efforts often rely on several criteria to engineer riboregulators of various types
with varying success [26, 33, 36, 69]. Based on these efforts, 12 features were defined and used
in a DOE to explore the tiRNA feature space. Subsequently, to improve the reliability of de
novo forward engineering of repressing riboregulators, a sequence-function model was con-
structed to link tiRNA functionality to the defined tiRNA features. To this end, both structural
and thermodynamic tiRNA features were used in a PLS regression model, which was evaluated
using an independent test set (R2 equal to 0.69). The success of this data driven approach indi-
cates the importance of machine learning techniques in modern synthetic biology to grasp the
ever increasing complexity of biological design. Furthermore, the complex nature of riboregu-
lation and the limited knowledge of the underlying working mechanisms makes engineering
RNA devices challenging. To this end, novel technologies (for instance SHAPE-Seq) enable
high-throughput study of the structure-function relationship of various types of riboregulators
in detail by combining RNA structural probing techniques and next-generation sequencing
technology, allowing better prediction of riboregulator performance [66, 67].
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